欢迎登录材料期刊网

材料期刊网

高级检索

用噁二唑硫酮杂环作为培氟沙星(1)的C3羧基电子等排体,得中间体C3噁二唑硫酮4(5),再将其与仲胺或取代苯胺及甲醛通过氨甲基化反应形成系列氟喹诺酮C3噁二唑硫酮曼尼希碱(6a ~6j)目标化合物.用元素分析、1H NMR和MS测试技术确证了目标化合物的组成和结构.采用MTT法评价了目标化合物对体外培养人肝癌Hep-3B细胞生长的抑制活性.结果表明,10种目标化合物活性均显著高于对照化合物1的活性,并且脂肪胺曼尼希碱的活性高于芳香胺曼尼希碱的活性.

参考文献

[1] Mavromoustakos T,Durdagi S,Koukoulitsa C,et al.Strategies in the Rational Drug Design[J].Curr Med Chem,2011,18(17):2517-2530.
[2] Meanwell N A.Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design[J].J Med Chem,2011,54(8):2529-2591.
[3] Abbanat D,Morrow B,Bush K,et al.New Agents in Development for the Treatment of Bacterial Infections[J].Curr Opin Pharmacol,2008,8 (5):582-582.
[4] Heeb S,Fletcher M P,Chhabra S R,et al.Quinolones:from Antibiotics to Autoinducers[J].FEMS Microbiol Res,2011,35(2):247-274.
[5] WANG Guoqiang,DUAN Nannan,CAO Tieyao,et al.Antitumor Agents of Fluoroquinolone C3 Isosteric Derivatives (Ⅰ)-Bis-oxadiazole Methyl-sulfide Derivatives[J].Chinese J Appl Chem,2012,29 (7):769-774 (in Chinese).王国强,段楠楠,曹铁耀,等.抗肿瘤氟喹诺酮C3等排衍生物(Ⅰ)—双噁二唑甲硫醚衍生物的合成和抗肿瘤活性[J].应用化学,2012,29(7):769-774.
[6] Weiner B,Szyma(n)ski W,Janssen D B,et al.Recent Advances in the Catalytic Asymmetric Synthesis of Beta-amino Acids[J].Chem Soc Rev,2010,39(5):1656-1691.
[7] Bayrak H,Demirbas A,Karaoglu S A,et al.Synthesis of Some New 1,2,4-Triazoles,Their Mannich and Schiff Bases and Evaluation of Their Antimicrobial Activities[J].Eur J Med Chem,2009,44(3):1057-1066.
[8] Manjunatha K,Poojary B,Lobo P L,et al.Synthesis and Biological Evaluation of Some 1,3,4-Oxadiazole Derivatives[J].Eur J Med Chem,2010,45(11):5225-5233.
[9] ZHANG Ziyi,ZHANG Yan,HUI Xinping,et al.Achievements on the Application of Hydrazine and Related Compounds for the Synthesis of Five-membered Azole Heterocycles[J].Chinese J Org Chem,2004,24 (11):1348-1365 (in Chinese).张自义,张艳,惠新平,等.肼类衍生物在五元唑类杂环合成中的应用进展[J].有机化学,2004,24(11):1348-1365.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%